Every year, lung cancer claims more lives in the United States than breast, colon, and prostate cancers combined. But here is the good news: the way we find it is changing fast. In 2026, we are seeing…
Every year, lung cancer claims more lives in the United States than breast, colon, and prostate cancers combined. But here is the good news: the way we find it is changing fast. In 2026, we are seeing…
You are in the ED or the ICU. A patient arrives with acute respiratory failure, diffuse crackles, and a chest X-ray that looks like bilateral whiteout. The clinical picture is muddy. Is this a fluid o…
For pulmonologists, internists, and respiratory therapists, preventing COPD exacerbations is a daily challenge. Every hospitalization represents a setback for the patient and a burden on the healthcar…
When a patient with severe asthma has tried every inhaler, failed on high dose corticosteroids, and still struggles to breathe, the conversation often turns to the newest biologic therapies. In 2026, …
Every pulmonologist knows the frustration: you see a COPD patient in the clinic every three to six months, take a single spirometry reading, and hope it reflects their true disease course. But lung fu…
As a parent, you know the pattern. School starts, and within a week your child comes home with a runny nose and a cough. You try hand washing, extra sleep, even elderberry syrup. But you keep hearing …
Sleep medicine is moving faster than ever. In 2026, the way we manage obstructive sleep apnea (OSA) looks almost unrecognizable from just a few years ago. New drug options are changing the conversatio…
You are looking at a spirometry report and the patient’s FEV1 dropped by 20% after inhaling methacholine. Is that enough to call it asthma? Not always. Bronchoprovocation testing is one of the most se…
For anyone living with cystic fibrosis, or caring for someone who does, the phrase “gene editing” can sound both thrilling and abstract. It promises a fix at the most fundamental level, a chance to co…
The landscape of pulmonary arterial hypertension (PAH) management is shifting faster than ever. For clinicians in 2026, staying on top of these changes is not just about keeping up with journals; it’s…